Authors


Deb Segura, The PDMA Alliance Inc.

Latest:

2015 PDMA Sharing Conference

A silver anniversary with golden opportunities


Tom Quinn, Physicians Interactive

Latest:

Landmarks to sampling in a digitized healthcare environment

The accelerating adoption of electronic health records, e-prescribing and mobile technologies will change the conventions of sample distribution


Shannon Curley, Jones Lang LaSalle

Latest:

A scientific approach to site selection

Applying a consistent framework to choose locations can help optimize R&D and drive cost reduction for pharmaceutical companies of all sizes


Stephen Rothenberg, Numerof & Associates, Inc.

Latest:

Defending Fair Market Value (FMV) Assessments

To avoid anti-kickback litigation with government, pharma companies need a defensible position on FMV assessments


By William King, Founder

Latest:

Powering up medical affairs

Technology is enabling more resources to reach the medical 
affairs teams—in a compliant manner


Daniel Perlman, Milliman Inc

Latest:

Medical-Claims Database Analysis of Off-Label Prescribing

Examining off-label use of highly prescribed drugs reveals factors that differ from the usual criticism of such usage


Dave Ulhrich, Abbott Labs

Latest:

Bringing room-temperature pharma shipping under the 'CRT' umbrella

'Controlled room temperature' (CRT) shipping is being transformed from standard shipping processes to engineered, compliance-ready processes and materials


Rob Sahr

Latest:

Protecting pharmaceutical exclusivity: Avoiding the hidden dangers of double patenting

Multiple patents contribute to a robust portfolio; however, each patent that issues can potentially become a landmine to another



Beth Hahn, PhD, United BioSource Corp.

Latest:

Evidence Generation Is the Foundation to Optimal Product Positioning

Evidence Generation Is the Foundation to Optimal Product Positioning


Joe Markmann, Wolters Kluwer Pharma Solutions, Wei Zhang, Long Island University

Latest:

How to Ensure Successful Design and Implementation of Physician Segmentation

The basic process of defining customer segments and appropriate promotional messaging benefits from a cross-disciplinary approach


Kori Anderson, Honeywell

Latest:

Thermoformable packaging’s role in an evolving pharmaceutical industry

Packaging materials have an impact in regulatory compliance, patient safety and drug efficacy


Dan Goldsmith, Veeva Network

Latest:

Network effect of industry-crowdsourced physician data

Diving for customer insights through an ocean of crowdsourced data


Scott Cubbler, Exel

Latest:

The Logistics of a Successful Product Launch

A collaborative working relationship gives launch day a better chance at success


Jeff Baker, NobleRx

Latest:

Educating patients on self-administered drug injections

The trend toward self-administered drugs creates a pressing need for better patient-education resources



Joseph Coppola

Latest:

A Data-Driven Approach to Contract Performance Monitoring and Analysis

Better use of available data can add rigor to analyzing managed-markets contracts, thereby allocating rebates / discounts more effectively


Tony Lanzone, Campbell Alliance

Latest:

Developing a comprehensive pre-launch trade and distribution strategy for specialty products

Establishing appropriate trade channels is crucial to the launch success of specialty pharmaceuticals



Gary Palgon, Liaison Technologies

Latest:

Getting value from Big Data

Setting a foundation for long-term success: How the pharmaceutical industry can transform Big Data into actionable insight


Harry Kerr and Thomas Schoenfelder, PhD, Caliper Corporation

Latest:

What Makes a Pharmaceutical Industry Leader?

Personality assessments identify the traits that enable some pharma researchers to ascend to leadership roles in industry


Agnes Shanley, Contributing Editor

Latest:

Outsourcing to innovate: the reinvention of pharma contract services

More complex products and higher risk are changing the nature of pharmaceutical outsourcing



Stefan Kloss, ZS Associates

Latest:

Unpacking Risk Sharing and Alternative Pricing Schemes

Shared-risk or ‘pay for performance’ agreements between drugmakers and payers can represent uncertain rewards for both parties. Use strategic planning before entering into them


Philip C. Bolger, McKesson Specialty Care Solutions

Latest:

Fine-Tuning Specialty Distribution

Specialty manufacturers have a range of options to consider in how to go to market


Mike Hennessy Sr., Chairman and Founder of MJH Life Sciences

Latest:

Building a better supply chain

Taking stock of lessons learned during pandemic—and opportunities to grow stronger


By Isabelle Noblanc, VP

Latest:

Managing employee training at the enterprise level

The case for a single enterprise-wide learning management system


Janardhan Vellore, Beghou Consulting

Latest:

Navigating Covid turbulence: How biopharmas are adapting their go-to-market strategies

Embracing digital channels and patient-centric strategies has been critical for commercial teams; a review of what some companies have done right


Terry Herring, Mission Pharmacal*

Latest:

Partnering to diversify yields rapid growth

A family-owned pharmaceutical manufacturer plots a 21st-century growth plan


By Peter Gilmore

Latest:

Specialty drug market access reality check

Ten payer pressures to act on now

© 2025 MJH Life Sciences

All rights reserved.